brainTale-care
BrainTaleProduct specifications |
Information source:
Vendor
Last updated: April 5, 2022 |
General | |
---|---|
Product name | brainTale-care |
Company | BrainTale |
Subspeciality | Neuro |
Modality | MR |
Disease targeted | Neurological disorders including traumatic brain injury, stroke, cardiac arrest, and neurodegenerative diseases |
Key-features | White matter quantification (global and regional), prognosis score for comatose patients after cardiac arrest and traumatic brain injuries |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion Without interference of a radiologist: AI-only diagnosis |
Data characteristics | |
Population | Adults patients with neurological disorders |
Input | Diffusion MRI, 3D T1-weighted MRI |
Input format | DICOM |
Output | Quantified values, prognosis scores, graphs, maps, videos, pdf reports |
Output format | Reports (*.pdf), figures (*.png), videos (*.mp4) |
Technology | |
Integration | Stand-alone webbased |
Deployment | Cloud-based |
Trigger for analysis | On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | > 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDR
|
FDA
|
No or not yet |
Market presence | |
On market since | 04-2022 |
Distribution channels | |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription, One-time license fee |
Based on | Number of users, Number of installations, Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |